Arkolith/Insider Trading/VTYX/Form 4

Nuss John

CHIEF SCIENTIFIC OFFICERVentyx Biosciences, Inc. (VTYX) · full profile →Form 4 · filed Apr 3, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$2K
Net Open-Market Flow
-$2K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 2, 2025Sell(S)2K$1.07$2K467K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-25-009944) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML